These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 31468273)

  • 21. Mothers' perspectives on challenging behaviours in their children with fragile X syndrome.
    Muller K; Brady NC; Warren SF; Fleming KK
    J Intellect Dev Disabil; 2019; 44(4):481-491. PubMed ID: 31896952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Initial severity and efficacy of risperidone in autism: Results from the RUPP trial.
    Levine SZ; Kodesh A; Goldberg Y; Reichenberg A; Furukawa TA; Kolevzon A; Leucht S
    Eur Psychiatry; 2016 Feb; 32():16-20. PubMed ID: 26802979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of response to antidepressant medications.
    Langee HR; Conlon M
    Am J Ment Retard; 1992 Jul; 97(1):65-70. PubMed ID: 1497865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risperidone for psychosis-induced aggression or agitation (rapid tranquillisation).
    Ostinelli EG; Hussein M; Ahmed U; Rehman FU; Miramontes K; Adams CE
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD009412. PubMed ID: 29634083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological intervention for irritability, aggression, and self-injury in autism spectrum disorder (ASD).
    Iffland M; Livingstone N; Jorgensen M; Hazell P; Gillies D
    Cochrane Database Syst Rev; 2023 Oct; 10(10):CD011769. PubMed ID: 37811711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia.
    Brodaty H; Ames D; Snowdon J; Woodward M; Kirwan J; Clarnette R; Lee E; Lyons B; Grossman F
    J Clin Psychiatry; 2003 Feb; 64(2):134-43. PubMed ID: 12633121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aripiprazole for the treatment of irritability associated with autism.
    Farmer CA; Aman MG
    Expert Opin Pharmacother; 2011 Mar; 12(4):635-40. PubMed ID: 21294670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atypical Antipsychotics for Irritability in Pediatric Autism: A Systematic Review and Network Meta-Analysis.
    Fallah MS; Shaikh MR; Neupane B; Rusiecki D; Bennett TA; Beyene J
    J Child Adolesc Psychopharmacol; 2019 Apr; 29(3):168-180. PubMed ID: 30707602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minimally effective doses of conventional antipsychotic medications used to treat aggression, self-injurious and destructive behaviors in mentally retarded adults.
    Janowsky DS; Barnhill LJ; Shetty M; Davis JM
    J Clin Psychopharmacol; 2005 Feb; 25(1):19-25. PubMed ID: 15643096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An analysis of challenging behavior, comorbid psychopathology, and Attention-Deficit/Hyperactivity Disorder in Fragile X Syndrome.
    Newman I; Leader G; Chen JL; Mannion A
    Res Dev Disabil; 2015 Mar; 38():7-17. PubMed ID: 25543996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial.
    Aman M; Rettiganti M; Nagaraja HN; Hollway JA; McCracken J; McDougle CJ; Tierney E; Scahill L; Arnold LE; Hellings J; Posey DJ; Swiezy NB; Ghuman J; Grados M; Shah B; Vitiello B
    J Child Adolesc Psychopharmacol; 2015 Aug; 25(6):482-93. PubMed ID: 26262903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brief report: aggression and stereotypic behavior in males with fragile X syndrome--moderating secondary genes in a "single gene" disorder.
    Hessl D; Tassone F; Cordeiro L; Koldewyn K; McCormick C; Green C; Wegelin J; Yuhas J; Hagerman RJ
    J Autism Dev Disord; 2008 Jan; 38(1):184-9. PubMed ID: 17340199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antipsychotic treatment of psychosis and agitation in the elderly.
    Daniel DG
    J Clin Psychiatry; 2000; 61 Suppl 14():49-52. PubMed ID: 11154017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risperidone in the management of agitation and aggression associated with psychiatric disorders.
    De Deyn PP; Buitelaar J
    Eur Psychiatry; 2006 Jan; 21(1):21-8. PubMed ID: 16414250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An indirect examination of the function of problem behavior associated with fragile X syndrome and Smith-Magenis syndrome.
    Langthorne P; McGill P
    J Autism Dev Disord; 2012 Feb; 42(2):201-9. PubMed ID: 21442360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose-dependent effect of risperidone treatment in a case of 22q13.3 deletion syndrome.
    Pasini A; D'Agati E; Casarelli L; Curatolo P
    Brain Dev; 2010 May; 32(5):425-7. PubMed ID: 19428206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risperidone for Psychosis-Induced Aggression or Agitation.
    Scruth E
    Issues Ment Health Nurs; 2019 Nov; 40(11):988-989. PubMed ID: 31381459
    [No Abstract]   [Full Text] [Related]  

  • 38. Olanzapine for self-injurious, aggressive, and disruptive behaviors in intellectually disabled adults: a retrospective, open-label, naturalistic trial.
    Janowsky DS; Barnhill LJ; Davis JM
    J Clin Psychiatry; 2003 Oct; 64(10):1258-65. PubMed ID: 14658977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of family financial and employment impacts of fragile X syndrome, autism spectrum disorders, and intellectual disability.
    Ouyang L; Grosse SD; Riley C; Bolen J; Bishop E; Raspa M; Bailey DB
    Res Dev Disabil; 2014 Jul; 35(7):1518-27. PubMed ID: 24755230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risperidone effects on irritable aggression in posttraumatic stress disorder.
    Monnelly EP; Ciraulo DA
    J Clin Psychopharmacol; 1999 Aug; 19(4):377-8. PubMed ID: 10440468
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.